AT THE FOREFRONT OF THERAPIES FOR RARE AND ORPHAN DISEASES Trademark

Trademark Overview

On Tuesday, May 22, 2012, a trademark application was filed for AT THE FOREFRONT OF THERAPIES FOR RARE AND ORPHAN DISEASES with the United States Patent and Trademark Office. The USPTO has given the AT THE FOREFRONT OF THERAPIES FOR RARE AND ORPHAN DISEASES trademark a serial number of 85631532. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, September 8, 2023. This trademark is owned by Amicus Therapeutics, Inc.. The AT THE FOREFRONT OF THERAPIES FOR RARE AND ORPHAN DISEASES trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Providing medical services for the treatment of diseases, namely, lysosomal storage disorders and diseases of neurodegeneration
at the forefront of therapies for rare and orphan diseases

General Information

Serial Number85631532
Word MarkAT THE FOREFRONT OF THERAPIES FOR RARE AND ORPHAN DISEASES
Filing DateTuesday, May 22, 2012
Status710 - CANCELLED - SECTION 8
Status DateFriday, September 8, 2023
Registration Number4295007
Registration DateTuesday, February 26, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 11, 2012

Trademark Statements

Goods and ServicesProviding medical services for the treatment of diseases, namely, lysosomal storage disorders and diseases of neurodegeneration

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, September 8, 2023
Primary Code044
First Use Anywhere DateSunday, January 15, 2012
First Use In Commerce DateSunday, January 15, 2012

Trademark Owner History

Party NameAmicus Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPhiladelphia, PA 19104
Party NameAmicus Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCranbury, NJ 08512
Party NameAmicus Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCranbury, NJ 08512

Trademark Events

Event DateEvent Description
Friday, September 8, 2023CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Saturday, February 26, 2022COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, January 28, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, January 28, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, January 28, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 28, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, January 28, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, March 27, 2019NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Wednesday, March 27, 2019REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, March 26, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, February 19, 2019TEAS SECTION 8 & 15 RECEIVED
Monday, February 26, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, May 8, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, May 8, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 20, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, August 20, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 26, 2013REGISTERED-PRINCIPAL REGISTER
Tuesday, December 11, 2012PUBLISHED FOR OPPOSITION
Wednesday, November 21, 2012NOTICE OF PUBLICATION
Thursday, November 8, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, November 7, 2012ASSIGNED TO LIE
Thursday, October 25, 2012EXAMINER'S AMENDMENT MAILED
Wednesday, October 24, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 24, 2012EXAMINER'S AMENDMENT ENTERED
Wednesday, October 24, 2012EXAMINERS AMENDMENT -WRITTEN
Wednesday, October 24, 2012PREVIOUS ALLOWANCE COUNT WITHDRAWN
Friday, September 28, 2012WITHDRAWN FROM PUB - OG REVIEW QUERY
Thursday, September 13, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 12, 2012ASSIGNED TO EXAMINER
Tuesday, May 29, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 25, 2012NEW APPLICATION ENTERED

Related Keywords

diseases orphan rare therapies forefront storage disorders neurodegeneration lysosomal namely services treatment providing medical